Arlington Trust’s HUTCHMED HCM Stock Holding History

Arlington Trust’s Portfolio HCM Stock Details HCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-86	Closed	-$1.56K	–	659
2023 Q4	$1.56K	Buy	+86	New	+$1.56K	﹤0.01%	704

Other funds holding HCM

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return

Arlington Trust's HCM Position: Q1 2024 in Review

Arlington Trust sold out of HUTCHMED (HCM) in Q1 2024, closing a stake of 86 shares — an estimated $1.56K sold.

Arlington Trust first reported a position in HCM in Q4 2023 and held it in 1 quarter. The position peaked at $1.56K in Q4 2023. 71 funds tracked by Wall St. Rank hold HCM as of Q1 2024.

Arlington Trust reported no remaining HUTCHMED position as of Q1 2024 after selling out during the quarter.
Arlington Trust sold 86 HUTCHMED shares in Q1 2024, an estimated $1.56K.
Arlington Trust first reported a position in HUTCHMED in Q4 2023 and held it in 1 quarter.
Arlington Trust's HUTCHMED position peaked at $1.56K in Q4 2023.
71 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2024.

Based on Arlington Trust's 13F filing for Q1 2024, filed 16 Apr 2024.